Skip to main content

Table 2 Comorbidities occurring in ≥2% of participants

From: Varenicline as a smoking cessation aid in a Greek population: a subanalysis of an observational study

Hypertension, n (%)

33 (16.8)

Chronic obstructive pulmonary disease, n (%)

16 (8.2)

Depression, n (%)

14 (7.1)

Diabetes mellitus, n (%)

11 (5.6)

Hypothyroidism, n (%)

8 (4.1)

Asthma, n (%)

8 (4.1)

Epilepsy, n (%)

6 (3.1)

Migraine, n (%)

4 (2.0)